Malaria vaccine disappoints in trial in African babies
LONDON (Reuters) - A GlaxoSmithKline experimental malaria vaccine touted as a new weapon in the fight to eradicate the disease proved only 30 percent effective when given to babies as part Africa's largest ever clinical trial. The surprisingly poor result for the world's first potential vaccine against malaria leaves uncertain whether it can have a useful role in fighting the mosquito-borne disease that kills hundreds of thousands of children a year. ...
Source: news.yahoo.com
No comments:
Post a Comment